As part of ICR, our clients span the Fortune 500, Nasdaq, FTSE 100, FTSEurofirst 300 and FTSE 250. ICR Consilium supports healthcare companies globally across all sub-sectors including life sciences, biopharma, medical technology, diagnostics, healthcare services and information technology, and through all stages of growth from early-stage development, to public offerings, to mature public companies. 


Latest news

20 May 2024

Clinical Trials Day

View news release Empty

Case studies

Osler Diagnostics

Osler is a UK-based diagnostics company whose purpose is to enable anyone, anywhere, to access, understand, and act on their health, to live healthier, happier, and longer lives.

Osler Diagnostics View all case studies

Our team


Our senior team has worked together for many years, delivering high-level strategic healthcare consultancy with seamless execution and unrivalled market intelligence.

View our team Empty